Mar 15, 2023 / 01:30PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
Good morning, everybody. I'm Luke Sergott, the life science tools diagnostics analyst here at Barclays. Today, I have Ron Bruehlman from IQVIA, CFO. And I think we can just probably get right into it, if it's good with you.
Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO
Okay. Great.
Questions and Answers:
Luke England Sergott - Barclays Bank PLC, Research Division - Research AnalystSo off the top here, let's go taking off the macro headwinds. Let's tick off the top today. SVB exposure and just walk us through that.
Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO
I figured that would probably be the first question. A week ago, I would have had no idea. But look, overall, what I would say is it's not a big concern for us at least so far as what we can see right now. And as far as our own relationship with SVB, we have no loans whatsoever with them. We